Gowling WLG’s global Life Sciences Group is heading to BIO International Convention 2026 in San Diego.

Our international team brings together deep sector knowledge and cross-border legal experience to support biopharma companies at every stage, from protecting innovation to executing complex transactions and expanding into new markets.

We will be on the ground throughout the conference and welcome the opportunity to connect. If you are attending, reach out to set up a meeting with our team in advance.

Advanced Business Development course: June 19 to 21

Ahead of the conference, Gowling WLG’s Pat Duxbury and Sharmela Kalmer will once again lead BIO’s Advanced Business Development course.

This three-day programme focuses on the transactional side of biopharma deals and offers practical insight into structuring, negotiating and executing successful agreements.